INCOG BioPharma completes installation of a filling line in Indiana, Recipharm invests in Lab+ filling technology in France, and WuXi Biologics expands its fill-finish capacity and capability in China. Welcome to our fill-finish roundup. First up is contract development manufacturing organization (CDMO) INCOG, which specializes in sterile injectables. The firm has completed the installation of its OPTIMA multi-use production filling line at its Fishers, Indiana plant. “The OPTIMA multi-use line serves as our highly customized, injectable therapy ‘bottling line’ at…